Moreover, analysis of tumor samples from patients with lung cancer as well as TCGA datasets confirmed that TLS increased in NSCLC tissues with lower ACAT1 and correlated with better immunotherapy outcomes. The gene discussed is ACAT1; the disease is neoplasm.